Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:06 AM
Ignite Modification Date:
2025-12-25 @ 5:06 AM
NCT ID:
NCT06242327
Eligibility Criteria:
Inclusion Criteria:
* Adults (≥18 years old) on the day of signing informed consent.
* Diagnosis of primary membranous nephropathy
* Nephrotic syndrome (proteinuria \>3.5 g/24 hours)
* Written informed consent to the use of recorded data for research purposes.
Exclusion Criteria:
* Legal incapacity or limited legal capacity.
* Any contraindication to treatment with rituximab or other monoclonal antibody
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06242327
Study Brief:
Protocol Section:
NCT06242327